Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-03-01 @ 8:57 PM
Study NCT ID:
NCT02505334
Status:
COMPLETED
Last Update Posted:
2018-09-05
First Post:
2015-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-21
First Submit QC Date:
None
Study First Post Date:
2015-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-26
Results First Submit QC Date:
None
Results First Post Date:
2018-06-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-31
Last Update Post Date:
2018-09-05
Last Update Post Date Type:
ACTUAL